Norris Medicines Ltd

Norris Medicines Q3 2025: Strong Revenue Growth & Profit Turnaround 📊

• Q3 2025 revenue: ₹326.66 lakhs, up from ₹110.60 lakhs in Q3 2024

• Q3 2025 profit before tax: ₹69.74 lakhs, compared to a loss of ₹28.17 lakhs in Q3 2024

• Nine-month loss before tax (ended Dec 31, 2025): ₹33.12 lakhs, reduced from a loss of ₹100.90 lakhs in the same period last year

• Favorable court order on November 19, 2025, resolved a previous demand of ₹1,32,92,359